Expertspeak
Not all Covid-19 patients need antivirals. New drugs for restricted use at physicians’ discretion: Cipla Ltd and Hetero Drugs have got authorisations for antiviral remdesivir for restricted emergency use, and Glenmark Pharmaceuticals, has got an approval for manufacture and marketing antiviral favipiravir. These medicines are likely to be available in the hands of medical professionals who are fighting Covid-19. How do these medicines work? What do we know of them today as opposed to what we knew of them earlier and what they were used for? And how are they likely to help the treatment of Covid-19 patients? Read this interview with Rommel Tickoo, associate director, internal medicine, at Max Healthcare, New Delhi.
Managing Covid-19
Guwahati lockdown explained: Here are the guidelines till July 12: A total lockdown will come into force in Assam’s Kamrup Metropolitan district — which includes Guwahati city — from June 28, 7 pm till July 12, 6 pm. The new lockdown guidelines are more stringent than the earlier guidelines. In a press conference on Friday, State Health Minister Himanta Biswa Sarma said this was a “stringent lockdown”, and “almost like a curfew. Read more here
Looking beyond just a testing milestone: As Tamil Nadu notched up its first million Covid-19 tests, the first to reach the milestone in the country, data on the number of tests being done in its different labs — 47 in the government sector and 42 in the private sector — have been made available. Read more here
OPINION
How Ramdev’s Coronil makes social media’s fight against misinformation more difficult: The introduction of a ‘cure’ and the resulting reaction — the Narendra Modi government’s AYUSH Ministry has asked Patanjali to stop advertising Coronil, and the Uttarakhand Ayurveda Department has said the company did not mention ‘coronavirus’ in its application seeking licence — raises an important debate on information disorder on social media platforms. And the question of what medical misinformation constitutes during times of a pandemic and otherwise. Read more here
Understanding Covid-19
Long road to recovery for discharged patients: Many recovered patients have complained of loss of taste, loss of smell, body fatigue, body pain, low blood pressure, stroke, blood sugar fluctuation and cardiac problems — now common signs during convalescence. Doctors across the city said apart from treating actively infected Covid-19 patients, they also have to monitor patients discharged after treatment. Patients are taking 3-4 weeks to regain their sense of taste, and longer for the sense of smell to return. Read more here
A sensor for flu and Covid-19 at the same time; can tell difference: Covid-19 shares number of symptoms with the common flu. Researchers are now developing a new sensor that can tell the difference between the two illnesses — and test for both simultaneously. A dual test improves on current options in several ways. It’s more convenient for patients who wouldn’t have to get multiple tests done. It also saves time for medical personnel when resources are stretched. Read more
To read the full story, Subscribe Now at just Rs 249 a month
Already a subscriber? Log in
Subscribe To BS Premium
₹249
Renews automatically
₹1699₹1999
Opt for auto renewal and save Rs. 300 Renews automatically
₹1999
What you get on BS Premium?
-
Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
-
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
Need More Information - write to us at assist@bsmail.in